CELSR1
Basic information
Region (hg38): 22:46360834-46537620
Links
Phenotypes
GenCC
Source:
- neural tube defects, susceptibility to (Moderate), mode of inheritance: AD
- neural tube defects, susceptibility to (Limited), mode of inheritance: AD
- lymphatic malformation 9 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lymphatic malformation 9 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular | 26855770; 31215153; 31403174 |
ClinVar
This is a list of variants' phenotypes submitted to
- Lymphatic malformation 9 (2 variants)
- Lymphatic malformation (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CELSR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 67 | 46 | 115 | |||
missense | 270 | 39 | 23 | 332 | ||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 1 | 9 | 10 | |||
non coding | 7 | |||||
Total | 2 | 4 | 283 | 108 | 77 |
Variants in CELSR1
This is a list of pathogenic ClinVar variants found in the CELSR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-46363187-CCTGATGGTTCAAATTGAAGTTTCATTA-C | Benign (Dec 31, 2019) | |||
22-46364011-T-G | not specified | Uncertain significance (Sep 29, 2022) | ||
22-46364022-G-T | not specified | Uncertain significance (Nov 15, 2021) | ||
22-46364032-C-T | not specified | Uncertain significance (May 04, 2022) | ||
22-46364041-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
22-46364043-G-C | CELSR1-related disorder | Benign (Dec 31, 2019) | ||
22-46364052-G-A | CELSR1-related disorder | Likely benign (Nov 21, 2019) | ||
22-46364070-C-T | CELSR1-related disorder | Benign (Dec 31, 2019) | ||
22-46364084-G-C | CELSR1-related disorder | Benign (Dec 31, 2019) | ||
22-46364120-A-G | Uncertain significance (Nov 13, 2023) | |||
22-46364122-C-T | Uncertain significance (Oct 27, 2023) | |||
22-46364131-G-A | not specified | Uncertain significance (Jul 26, 2021) | ||
22-46364133-CGTGCGCGAGGAT-C | CELSR1-related disorder | Benign (Nov 30, 2017) | ||
22-46364139-C-T | CELSR1-related disorder | Likely benign (Apr 22, 2022) | ||
22-46364140-G-A | CELSR1-related disorder | Benign (Feb 21, 2020) | ||
22-46364168-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
22-46364179-C-T | not specified | Uncertain significance (Oct 05, 2022) | ||
22-46364180-G-A | not specified | Uncertain significance (Jul 21, 2021) | ||
22-46364186-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
22-46364189-C-T | CELSR1-related disorder | Benign (Oct 12, 2018) | ||
22-46364197-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
22-46364205-C-T | CELSR1-related disorder | Benign (Feb 21, 2020) | ||
22-46364206-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
22-46364218-G-T | not specified | Conflicting classifications of pathogenicity (Oct 01, 2022) | ||
22-46364224-G-A | Uncertain significance (Aug 02, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CELSR1 | protein_coding | protein_coding | ENST00000262738 | 35 | 176337 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000598 | 121369 | 365 | 4014 | 125748 | 0.0176 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.20 | 1731 | 1.88e+3 | 0.922 | 0.000136 | 19376 |
Missense in Polyphen | 700 | 907.13 | 0.77166 | 8887 | ||
Synonymous | -3.54 | 1003 | 870 | 1.15 | 0.0000735 | 6342 |
Loss of Function | 7.97 | 18 | 107 | 0.168 | 0.00000558 | 1149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.228 | 0.224 |
Ashkenazi Jewish | 0.00438 | 0.00428 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.00413 | 0.00231 |
European (Non-Finnish) | 0.0104 | 0.00590 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.00359 | 0.00193 |
Other | 0.0121 | 0.0101 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor that may have an important role in cell/cell signaling during nervous system formation.;
- Disease
- DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22095531}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
- Pathway
- GPCRs, Other
(Consensus)
Recessive Scores
- pRec
- 0.148
Intolerance Scores
- loftool
- 0.157
- rvis_EVS
- -2.82
- rvis_percentile_EVS
- 0.63
Haploinsufficiency Scores
- pHI
- 0.504
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.804
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Celsr1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; vision/eye phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- establishment of planar polarity;neuron migration;neural tube closure;hair follicle development;homophilic cell adhesion via plasma membrane adhesion molecules;G protein-coupled receptor signaling pathway;Rho protein signal transduction;central nervous system development;locomotory behavior;anterior/posterior pattern specification;regulation of actin cytoskeleton organization;wound healing;establishment of planar polarity of embryonic epithelium;inner ear morphogenesis;apical protein localization;establishment of body hair planar orientation;Wnt signaling pathway, planar cell polarity pathway;orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis;planar dichotomous subdivision of terminal units involved in lung branching morphogenesis;lateral sprouting involved in lung morphogenesis;planar cell polarity pathway involved in neural tube closure;protein localization involved in establishment of planar polarity
- Cellular component
- nucleoplasm;plasma membrane;integral component of plasma membrane;integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;G protein-coupled receptor activity;calcium ion binding;protein dimerization activity